{
  "id": 1033,
  "text": "This consultation should encompass the risk of FST abandonment if there are positive margins or LN involvement and oncologic and obstetric risks related to this type of management.FST should not be recommended for rare histological subtypes of cervical cancer including neuroendocrine carcinomas and non-HPV-related adenocarcinomas (except for adenoid basal carcinoma), which tend to exhibit aggressive behavior.",
  "ChatGPT_query": "Please create a <question> that closely aligns with the provided <text>. Ensure that the <question> is formulated in Chinese and does not explicitly reference the text. You may incorporate specific scenarios or contexts in the <question>, allowing the <text> to serve as a comprehensive and precise answer.\n\n<text>: This consultation should encompass the risk of FST abandonment if there are positive margins or LN involvement and oncologic and obstetric risks related to this type of management.FST should not be recommended for rare histological subtypes of cervical cancer including neuroendocrine carcinomas and non-HPV-related adenocarcinomas (except for adenoid basal carcinoma), which tend to exhibit aggressi\n\n<question>: \n\n**如果text中内容跟宫颈癌无关，请回复'SKIP'**\n",
  "ChatGPT_response_0": "在宫颈癌的治疗过程中，术中出现阳性切缘或淋巴结受累的风险需要特别关注，这通常不适合继续进行保留生育功能的手术（FST）。这是因为这些情况可能增加肿瘤复发和转移的风险，因此需要权衡肿瘤学和生育的需求。如果术中确定有阳性切缘或淋巴结受累，一般情况下建议转向更为彻底的治疗方式，如根治性手术加辅助治疗，以确保患者的长期疗效。\n\n对于某些罕见的病理亚型，例如神经内分泌癌和非HPV相关的腺癌（除腺样基底细胞癌外），由于其具有较高的侵袭性和不良的预后，通常不建议进行保留生育功能的手术。这是因为上述病理亚型的生物学行为更具攻击性，优先考虑的是控制疾病进展，而非生育功能的保留。\n\n综上，在治疗方案中需要综合考虑病理类型、肿瘤的扩散情况（如切缘或淋巴结是否受累）、肿瘤学风险和生育需求，制定个体化的治疗计划。",
  "query": "在宫颈癌的治疗方案中，如何考虑术中出现阳性切缘或淋巴结受累的风险，以及是否适合针对某些罕见的病理亚型推荐保留生育功能的手术？",
  "ChatGPT_query_a": "You are HuatuoGPT-II, equipped with in-depth knowledge in medicine. Your task is to directly answer the user's <question> in Chinese. In formulating your response, you must thoughtfully reference the <reference text>, ensuring that your reply does not disclose your reliance on <reference text>. Aim to provide a comprehensive and informative response, incorporating relevant insights from <reference text> to best assist the user. Please be cautious to avoid including any content that might raise ethical concerns.\n\n<question>: 在宫颈癌的治疗方案中，如何考虑术中出现阳性切缘或淋巴结受累的风险，以及是否适合针对某些罕见的病理亚型推荐保留生育功能的手术？\n\n<reference text>: This consultation should encompass the risk of FST abandonment if there are positive margins or LN involvement and oncologic and obstetric risks related to this type of management.FST should not be recommended for rare histological subtypes of cervical cancer including neuroendocrine carcinomas and non-HPV-related adenocarcinomas (except for adenoid basal carcinoma), which tend to exhibit aggressive behavior.\n\n**如果text中内容跟宫颈癌无关，请回复'SKIP'**\n\n<reply>: ",
  "response": "在宫颈癌的治疗过程中，术中出现阳性切缘或淋巴结受累的风险需要特别关注，这通常不适合继续进行保留生育功能的手术（FST）。这是因为这些情况可能增加肿瘤复发和转移的风险，因此需要权衡肿瘤学和生育的需求。如果术中确定有阳性切缘或淋巴结受累，一般情况下建议转向更为彻底的治疗方式，如根治性手术加辅助治疗，以确保患者的长期疗效。\n\n对于某些罕见的病理亚型，例如神经内分泌癌和非HPV相关的腺癌（除腺样基底细胞癌外），由于其具有较高的侵袭性和不良的预后，通常不建议进行保留生育功能的手术。这是因为上述病理亚型的生物学行为更具攻击性，优先考虑的是控制疾病进展，而非生育功能的保留。\n\n综上，在治疗方案中需要综合考虑病理类型、肿瘤的扩散情况（如切缘或淋巴结是否受累）、肿瘤学风险和生育需求，制定个体化的治疗计划。"
}